This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Feb;74(2):e13440.

doi: 10.1111/ijcp.13440.

Letter re: Article by Palm J et al Int J Clin Pract. 2018 Oct 17; 72:e13272

Adrian Shephard¹, Anuradha Kulasekaran¹, Neil Fawkes¹, Adam Smith¹, Darren Targett²

Affiliations

PMID: 31633267
DOI: 10.1111/ijcp.13440

Comment

Letter re: Article by Palm J et al Int J Clin Pract. 2018 Oct 17; 72:e13272

Adrian Shephard et al. Int J Clin Pract. 2020 Feb.

. 2020 Feb;74(2):e13440.

doi: 10.1111/ijcp.13440.

Authors

Adrian Shephard¹, Anuradha Kulasekaran¹, Neil Fawkes¹, Adam Smith¹, Darren Targett²

Affiliations

¹ Reckitt Benckiser, Slough, UK.
² Primoriscs Contract Solutions, Ascot, UK.

PMID: 31633267
DOI: 10.1111/ijcp.13440

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of a triple active sore throat lozenge in the treatment of patients with acute pharyngitis: Results of a multi-centre, randomised, placebo-controlled, double-blind, parallel-group trial (DoriPha).
Palm J, Fuchs K, Stammer H, Schumacher-Stimpfl A, Milde J; DoriPha investigators. Palm J, et al. Int J Clin Pract. 2018 Dec;72(12):e13272. doi: 10.1111/ijcp.13272. Epub 2018 Oct 17. Int J Clin Pract. 2018. PMID: 30329199 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information